Evaluation of a Software to Predict the Postoperative Component Position in Total Hip Arthroplasty (THA)

NCT ID: NCT07107282

Last Updated: 2025-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-30

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to learn about the accuracy of a software determining the implant position during THA surgery.

Measurements made with the software are compared to reference values determined on X-rays.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The software is based on comparing an pre-operative fluoroscopy-based image with inter-operative fluoroscopy-based image. Three numerical values are provided: "leg length", "lateral offset" and "inclination".

Correponding reference values are determined based on pre-operative and post-operative X-rays.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All patients

All patients included in the study

MyHip Verifier

Intervention Type DEVICE

Numerical information on the position of the implant is provided to the surgeon.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MyHip Verifier

Numerical information on the position of the implant is provided to the surgeon.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Scheduled for THA
2. Age of 18 or above

Exclusion Criteria

1. Patients with anatomical conditions which reduce the applicability of the software
2. Patients with implants which reduce the applicability of the software
3. Patients who cannot perform an upright X-ray
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Basel Academy for Quality and Research in Medicine

UNKNOWN

Sponsor Role collaborator

Marcel Jakob

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marcel Jakob

Prof. Dr.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcel Jakob, MD

Role: PRINCIPAL_INVESTIGATOR

crossklinik AG

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marcel Jakob, MD

Role: CONTACT

+41 61 285 1042

Werner Vach, PhD

Role: CONTACT

+41 61 285 1034

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VerifierVerifier

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dual Mobility in "High Risk" Patients
NCT04092634 ACTIVE_NOT_RECRUITING PHASE4